NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Real-world Immunogenicity of Anti-IL5/5a Antibody

Active Not RecruitingN/A

Sponsor: Samsung Medical Center

Conditions: Asthma, Immunogenicity, Biologics

Countries: South Korea

This study aims to evaluate the immunogenicity of the drug by measuring anti-drug antibody (ADA) formation and titers. The presence of ADAs will be assesses to determine their potential impact on the drug's efficacy and safety.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients with severe asthma

Exclusion Criteria:

* History of hypersensitivity reactions to biologics (anti IL5 or IL5Ra)

Locations (1)

Seoul, South Korea